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Topic 07 – Basic science
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Introduction: Replicative senescence is characterized by a limited ability
of cells to divide in-vitro. Senescence induces an endothelial dysfunction.
Many compounds in food can induce an earlier vascular senescence. Acry-
lamide (AAM) is a recent discovery in food, as a Maillard reaction product.
After ingestion, AAM is in part metabolized to glycidamide (GA) in the liver.
AAM and GA have been described as “probably carcinogenic to human”,
reprotoxic and neurotoxic in animals. However, endothelial toxicity of AAM
has never been studied.
Objective: To assess the effects of AAM on endothelium.
Methods: To evaluate endothelial dysfunction, mice have been fed with
AAM-enriched diets (25, 50 or 100μg/kgBW/day) for 3, 6 or 9 months. Endo-
thelium-dependent relaxation (EDR) of aortic rings was measured. AAM
(1-50mM) and GA (1-5mM) toxicity was assessed by measuring Human
Umbilical Vein Endothelial Cells (HUVEC) proliferation by MTS test and cell
death induction by flow cytometry. Senescence was evaluated in HUVEC
cultured over 3 months with AAM or GA (10 or 100μm) by measuring β-
galactosidase activity (flow cytometry) and telomere length (qPCR).
Results: After 6 months of diet, AAM (100μg/kgBW/day) decreased aortic
EDR (p<0.01). In-vitro, AAM (≥5 mm) inhibited in dose- and time-dependent
manners HUVEC proliferation (p<0.001) and induced apoptosis (p<0.05). GA
exhibited higher toxicity since lower doses were needed to induce same
results. The extended culture with AAM or GA demonstrated a significant cell
division slowdown and increased β-galactosidase activity.AAM or GA
(100μm) accelerated telomere shortening (p<0.05).
Discussion: The toxicity of AAM and GA on endothelial cells in vitro is
characterized by decreased proliferation and induction of cell death at high
doses. Chronic exposure at lower concentrations induce an accelerated senes-
cence, potentially the cause of endothelial dysfunction in-vivo.
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Serum homocysteine thiolactonase activity is closely related to homocysteine
and ox-LDL levels in coronary artery disease patients. Homocysteine thiolac-
tonase activities are the result of environmental factors and genetic polymor-
phisms of paroxosonase. The relevance of gene polymorphism in coronary
patients with or without diabetes was investigated in a case-control study. 
Methods: The population included 140 control subjects, 47 coronary artery
disease patient without diabetes and 44 patients with type 2 diabetes. 
Results: Serum thiolactonase activity decreased significantly in coronary
artery disease patients: 318.9±156 U/l those without diabetes and 388.8±180
in the diabetic ones compared with the controls: 568.8±250U/l (p<0.001).
These activities were associated with increased plasma homocysteine and ox-
LDL levels (p<0.001). The paroxonase allele frequency is significantly higher
in controls than coronary artery patients (p<0.001). The frequency of R high
activity allele was also higher in diabetic coronary patients (11.3%), than in
those without diabetes (4.2%). No significant association was found between
paroxonase LN gene polymorphisms and diabetes in coronary patients. 
Conclusions: The difference in allele frequency for the paroxonase R gene
polymorphism may be the cause of the high thiolactonase activity observed in
coronary patients with type 2 diabetes mellitus. Further studies are needed to
be conducted to elucidate the role of the enzyme in the development of vas-
cular complications in these patients.
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Introduction: Rasagiline, (R) mesylate (N-propargyl-1 (R)-aminoindan) is
a selective, potent irreversible inhibitor of MAO-B with neuroprotective and
anti-apoptotic properties. 
Purpose: We investigated whether R could provide cardioprotection in a
6 month Wistar male rat model (350-400gr) undergoing experimental Myo-
cardial Infarction (MI). 
Methods: MI was induced surgically by a permanent ligation of the left
anterior descending coronary artery. We included 3 experimental groups:
R (n=10), Control (C) (n=10), and sham-operated (S) (n=10). R was adminis-
tered daily (2mg/kg i.p.) for 4 weeks, beginning 24 hours after MI induction.
Group C received normal saline 0.9%, i.p. Cardiac function was assessed by
two-dimensional targeted M-mode echocardiography (Vivid 7, 13MHz), at
baseline, 14 and 28 days post MI. Estimation of cardiac remodeling and cardio-
myocyte damage was performed by immuno-fluorescent microscopy analysis. 
Results: Baseline measurements were similar in all groups. Group R showed
less FS (%) deterioration vs group C at 14 (31.4±2.1 vs 22.3±2.0, p<0.0001) and
28 days (31.6±2.3vs19.6±1.8, p<0.0001). Immuno-fluorescent microscopy anal-
ysis of the infract border zone indicated reduced collagen I staining in group R
(n=3) rats compared to group C (n=3) and less cardiomyocyte degeneration as
indicated by b-catenin and desmin staining. Also, apoptosis (TUNEL) was
reduced by 65% in the border zone and 58% in the remote region of R treated
animals. Importantly, scar size did not differ among the two groups.
Conclusions: Our study showed attenuation in cardiac remodelling after
MI as presented by better systolic function in Rasagiline mesylate (a
commonly used neurological drug) treated rats accompanied by less border
zone fibrosis and cardiomyocyte degeneration indicating a beneficial effect in
the post-MI period. 
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Background and aim: The association between polymorphisms in the p53
tumour suppressor gene and CAD has been reported. However, not all inves-
tigations have been consistent, and this hypothesized association remains
controversial. The aim of this study was to investigate the possible association
between the MspI in intron 6 polymorphism in the p53 gene and myocardial
infarction (MI) in Tunisian subjects.
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Materials and methods: A total of 246 unrelated patients with MI (27-69
years old) and 230 healthy controls (35-69 years old) were included in this study.
The MspI polymorphism of the p53 gene was evaluated by PCR-RFLP method.
Results: The genotype distribution for the MspI variant of the p53 gene in
MI patients (M1M1: n=115, 46.7%; M1M2: n=122, 49.6%; M2M2: n=9,
3.7%) and controls (M1M1: n = 134, 58.3%; M1M2: n = 92, 40.0%; M2M2:
n=4, 1.7%) was significantly different (p = 0.029). Similarly, the allelic fre-
quency was also different (p = 0.017). The odds ratio for MI related to the M2
allele was 1.43 (95% CI=1.05 – 1.95).
Conclusion: These results suggest that the MspI polymorphism of the p53
gene is associated with MI in Tunisian population. 
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Introduction: Paraoxonase 2 (PON2) has antioxidant properties similar to
paraoxonase-1 and paraoxonase-3. However, in contrast to paraoxonase-1 and
paraoxonase-3, paraoxonase-2 is not associated with high-density lipoproteins
and may only exert its antioxidant function at the cellular level. PON2 may
also play a role in the pathogenesis of arterial thrombosis and atherosclerosis.
The purpose of the present study was to investigate the possible association
between the Cys311Ser polymorphism of PON2 gene and myocardial infarc-
tion (MI) in the Tunisian male population
Materials and methods: A total of 700 unrelated Tunisian subjects
including 321 patients with MI and 379 healthy controls were included in this
study. Genomic DNA was extracted from peripheral blood leukocytes
according to standard methods. PON2 genotypes were determined by PCR-
RFLP method.
Results: A significant difference in genotype distribution and allele fre-
quencies was observed between MI patients and controls. Patients with MI
had a frequency of 17.1% for CC genotype, 45.8% for the CS genotype and
37.1% for the SS genotype. The controls had a frequency of 26.1% for the CC
genotype, 45.6% for the CS genotype and 28.2% for the SS genotype
(χ²=10.58; p=0.005). The MI patient group showed a significantly higher fre-
quency of the S allele compared to the controls (0.60 vs 0.51; χ² =11.16;
p<0.001). In multivariate analysis, C311S polymorphism was independently
associated with MI (p<0.001).
Conclusion: Our results showed a significant and independent association
between the PON2 C311S polymorphism (presence of S allele) and MI in the
Tunisian male population. 
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